Literature DB >> 18608114

Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization.

George Davey Smith1, Nic Timpson, Shah Ebrahim.   

Abstract

Observational studies have contributed in a major way to understanding modifiable determinants of cardiovascular disease risk, but several examples exist of factors that were identified in observational studies as potentially protecting against coronary heart disease, that in randomized controlled trials had no such effect. The likely reason for misleading findings from observational epidemiological studies is that associations are influenced by confounding, bias, and reverse causation--where disease influences a risk factor, rather than vice versa. Mendelian randomization utilizes genetic variants that serve as proxy measures for modifiable risk factors to allow estimation of the causal influence of the modifiable risk factor in question. We present examples of the use of the Mendelian randomization approach and discuss both the limitations and potentials of this strategy.

Entities:  

Mesh:

Year:  2008        PMID: 18608114     DOI: 10.1080/07853890802010709

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  39 in total

1.  Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma.

Authors:  Sergio Fazio; MacRae F Linton
Journal:  J Clin Endocrinol Metab       Date:  2009-04       Impact factor: 5.958

2.  Mendelian randomization: loosening the Gordian knot of testosterone and male ageing.

Authors:  David J Handelsman
Journal:  Asian J Androl       Date:  2013-06-17       Impact factor: 3.285

Review 3.  Spontaneous arterial dissection: phenotype and molecular pathogenesis.

Authors:  Caspar Grond-Ginsbach; Rastislav Pjontek; Suna Su Aksay; Alexander Hyhlik-Dürr; Dittmar Böckler; Marie-Luise Gross-Weissmann
Journal:  Cell Mol Life Sci       Date:  2010-02-14       Impact factor: 9.261

4.  An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease.

Authors:  Jianjun Gao; Hong Xu; Clarice Weinberg; Xuemei Huang; Yikyung Park; Albert Hollenbeck; Aaron Blair; Arthur Schatzkin; Lauranell Burch; Honglei Chen
Journal:  Neurodegener Dis       Date:  2011-01-13       Impact factor: 2.977

Review 5.  Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

6.  Cross-sectional population associations between detailed adiposity measures and C-reactive protein levels at age 6 years: the Generation R Study.

Authors:  L Toemen; O Gishti; S Vogelezang; R Gaillard; A Hofman; O H Franco; J F Felix; V W V Jaddoe
Journal:  Int J Obes (Lond)       Date:  2015-04-29       Impact factor: 5.095

7.  Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How.

Authors:  John F Trepanowski; John P A Ioannidis
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

8.  Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach.

Authors:  Paul Welsh; Eliana Polisecki; Michele Robertson; Sabine Jahn; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Aroon D Hingorani; George Davey Smith; Ernst Schaefer; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

9.  Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.

Authors:  Nadeem Sarwar; Manjinder S Sandhu; Sally L Ricketts; Adam S Butterworth; Emanuele Di Angelantonio; S Matthijs Boekholdt; Willem Ouwehand; Hugh Watkins; Nilesh J Samani; Danish Saleheen; Debbie Lawlor; Muredach P Reilly; Aroon D Hingorani; Philippa J Talmud; John Danesh
Journal:  Lancet       Date:  2010-05-08       Impact factor: 79.321

10.  A non-synonymous variant in ADH1B is strongly associated with prenatal alcohol use in a European sample of pregnant women.

Authors:  Luisa Zuccolo; Nicola Fitz-Simon; Ron Gray; Susan M Ring; Kapil Sayal; George Davey Smith; Sarah J Lewis
Journal:  Hum Mol Genet       Date:  2009-08-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.